266 related articles for article (PubMed ID: 7493617)
41. Functional interaction between alpha2-adrenoceptors, mu- and kappa-opioid receptors in the guinea pig myenteric plexus: effect of chronic desipramine treatment.
Canciani L; Giaroni C; Zanetti E; Giuliani D; Pisani R; Moro E; Trinchera M; Crema F; Lecchini S; Frigo G
Eur J Pharmacol; 2006 Dec; 553(1-3):269-79. PubMed ID: 17055479
[TBL] [Abstract][Full Text] [Related]
42. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinans.
Ananthan S; Kezar HS; Saini SK; Khare NK; Davis P; Dersch CM; Porreca F; Rothman RB
Bioorg Med Chem Lett; 2003 Feb; 13(3):529-32. PubMed ID: 12565965
[TBL] [Abstract][Full Text] [Related]
44. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
45. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
[TBL] [Abstract][Full Text] [Related]
46. Predominance of delta-opioid-binding sites in the porcine enteric nervous system.
Townsend D; Brown DR
J Pharmacol Exp Ther; 2002 Mar; 300(3):900-9. PubMed ID: 11861796
[TBL] [Abstract][Full Text] [Related]
47. Partial agonistic effect of 9-hydroxycorynantheidine on mu-opioid receptor in the guinea-pig ileum.
Matsumoto K; Takayama H; Ishikawa H; Aimi N; Ponglux D; Watanabe K; Horie S
Life Sci; 2006 Apr; 78(19):2265-71. PubMed ID: 16266723
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
[TBL] [Abstract][Full Text] [Related]
49. Involvement of the cannabinoid CB1 receptor in the opioid inhibition of the response to cholecystokinin and acute withdrawal response.
Romanelli L; Palmery M; Tucci P; Amico MC; Morrone LA; Valeri P
Neurotoxicology; 2005 Oct; 26(5):819-27. PubMed ID: 15913779
[TBL] [Abstract][Full Text] [Related]
50. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
Pick CG; Peter Y; Schreiber S; Weizman R
Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
[TBL] [Abstract][Full Text] [Related]
51. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
52. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Wang D; Sun X; Sadee W
J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
[TBL] [Abstract][Full Text] [Related]
53. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
54. The hypothesis that antagonism of fentanyl analgesia by 2-chloroprocaine is mediated by direct action on opioid receptors.
Coda B; Bausch S; Haas M; Chavkin C
Reg Anesth; 1997; 22(1):43-52. PubMed ID: 9010946
[TBL] [Abstract][Full Text] [Related]
55. Beta-funaltrexamine discriminates between two subtypes of mu2-opioid receptors in electrically stimulated longitudinal muscle of guinea pig ileum.
Takayanagi I; Okayasu A; Koike K; Suzuki T; Kizawa Y
Gen Pharmacol; 1998 Aug; 31(2):215-20. PubMed ID: 9688462
[TBL] [Abstract][Full Text] [Related]
56. Inhibitory effects of opioids in a circular muscle-myenteric plexus preparation of guinea-pig ileum.
Johnson SM; Costa M; Humphreys CM; Shearman R
Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):419-24. PubMed ID: 2829034
[TBL] [Abstract][Full Text] [Related]
57. Multiple opiate receptors in the guinea pig enteric nervous system: unmasking the copresence of receptor subtypes.
Gintzler AR; Hyde D
Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2252-4. PubMed ID: 6326116
[TBL] [Abstract][Full Text] [Related]
58. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues.
Sayre LM; Larson DL; Takemori AE; Portoghese PS
J Med Chem; 1984 Oct; 27(10):1325-35. PubMed ID: 6090663
[TBL] [Abstract][Full Text] [Related]
59. The antitussive activity of delta-opioid receptor stimulation in guinea pigs.
Kotzer CJ; Hay DW; Dondio G; Giardina G; Petrillo P; Underwood DC
J Pharmacol Exp Ther; 2000 Feb; 292(2):803-9. PubMed ID: 10640321
[TBL] [Abstract][Full Text] [Related]
60. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG
Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
